|
|
|
|
LEADER |
03367nam a22005175i 4500 |
001 |
978-3-319-42934-2 |
003 |
DE-He213 |
005 |
20210617053856.0 |
007 |
cr nn 008mamaa |
008 |
170118s2016 gw | s |||| 0|eng d |
020 |
|
|
|a 9783319429342
|9 978-3-319-42934-2
|
024 |
7 |
|
|a 10.1007/978-3-319-42934-2
|2 doi
|
050 |
|
4 |
|a RC254-282
|
072 |
|
7 |
|a MJCL
|2 bicssc
|
072 |
|
7 |
|a MED062000
|2 bisacsh
|
072 |
|
7 |
|a MJCL
|2 thema
|
082 |
0 |
4 |
|a 616.994
|2 23
|
245 |
1 |
0 |
|a Current Strategies in Cancer Gene Therapy
|h [electronic resource] /
|c edited by Wolfgang Walther.
|
250 |
|
|
|a 1st ed. 2016.
|
264 |
|
1 |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2016.
|
300 |
|
|
|a V, 121 p. 13 illus., 7 illus. in color.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
490 |
1 |
|
|a Recent Results in Cancer Research,
|x 0080-0015 ;
|v 209
|
505 |
0 |
|
|a Cancer Gene therapy trials worldwide -- Viral vectors for cancer gene therapy -- Nonviral vectors for cancer gene therapy -- Delivery systems for cancer gene therapy -- Targeted vectors for cancer gene therapy -- Current strategies for cancer suicide gene therapy -- Stem cell guided gene therapy for cancer -- Gene replacement therapy to treat cancer -- miRNA for cancer gene therapy -- Gene suppression gene therapy for cancer -- Recent developments in oncolytic virus therapy -- DNA vaccination for cancer therapy -- mRNA based cancer vaccines -- Engineered T-cells to treat cancer -- Gene therapy for overcoming drug resistance.
|
520 |
|
|
|a This book describes important developments and emerging trends in experimental and clinical cancer gene therapy. It reflects the tremendous advances made over recent years with respect to immunogenes, suicide genes and gene correction therapies, as well as in gene suppression and miRNA therapies. Many of the described strategies focus on the generation of more efficient and specific means of attack at known and novel cellular targets associated with tumor development and progression. The book also details parallel improvements in vector design, vector delivery, and therapeutic efficacy. It offers readers a stimulating, broad overview of advances in the field, linking experimental strategies to their clinical applications.
|
650 |
|
0 |
|a Oncology .
|
650 |
|
0 |
|a Cancer research.
|
650 |
|
0 |
|a Gene therapy.
|
650 |
1 |
4 |
|a Oncology.
|0 https://scigraph.springernature.com/ontologies/product-market-codes/H33160
|
650 |
2 |
4 |
|a Cancer Research.
|0 https://scigraph.springernature.com/ontologies/product-market-codes/B11001
|
650 |
2 |
4 |
|a Gene Therapy.
|0 https://scigraph.springernature.com/ontologies/product-market-codes/B12020
|
700 |
1 |
|
|a Walther, Wolfgang.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer Nature eBook
|
776 |
0 |
8 |
|i Printed edition:
|z 9783319429328
|
776 |
0 |
8 |
|i Printed edition:
|z 9783319429335
|
776 |
0 |
8 |
|i Printed edition:
|z 9783319826974
|
830 |
|
0 |
|a Recent Results in Cancer Research,
|x 0080-0015 ;
|v 209
|
856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-319-42934-2
|
912 |
|
|
|a ZDB-2-SME
|
912 |
|
|
|a ZDB-2-SXM
|
950 |
|
|
|a Medicine (SpringerNature-11650)
|
950 |
|
|
|a Medicine (R0) (SpringerNature-43714)
|